mRNA vaccines — a new era in vaccinology

Pardi, Norbert, Hogan, Michael J., Porter, Frederick W., Weissman, Drew·2018·Nature Reviews Drug Discovery

Cited by (1,011)

Items 201–300 of 1,011

  1. Comparison of DNA and mRNA vaccines against cancer
    Zohreh Jahanafrooz, Behzad Baradaran, Jafar Mosafer, Mahmoud Hashemzaei, Tayebeh Rezaei, Ahad Mokhtarzadeh, Michael Richard Hamblin · 2019 · Drug Discovery Today
  2. Antibiotic resistance in agriculture: Perspectives on upcoming strategies to overcome upsurge in resistance
    Avantika Mann, Kiran Nehra, Jogender Singh Rana, Twinkle Dahiya · 2021 · Current Research in Microbial Sciences
  3. Biomaterials for vaccine-based cancer immunotherapy
    Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell · 2018 · Journal of Controlled Release
  4. Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
    Wenxing Gu, Fenghua Meng, Rainer Haag, Zhiyuan Zhong · 2020 · Journal of Controlled Release
  5. Tapping the RNA world for therapeutics
    Judy Lieberman · 2018 · Nature Structural & Molecular Biology
  6. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System
    Pattipeiluhu, Roy, Arias‐Alpizar, Gabriela, Basha, Genc, Chan, Karen Y. T., Bussmann, Jeroen, Sharp, Thomas H., Moradi, Mohammad‐Amin, Sommerdijk, Nico, Harris, Edward N., Cullis, Pieter R. et al. · 2022 · Advanced Materials
  7. Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
    Nicholas George Kounis, Ioanna C. Koniari, Cesare DE GREGORIO, Dimitris Velissaris, Konstantinos Petalas, Aikaterini Brinia, Stelios F. Assimakopoulos, Christos Gogos, Sophia N. Kouni, George N. Kounis et al. · 2021 · Vaccines
  8. Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation
    Anne-Line Coolen, Céline Lacroix, Perrine Mercier‐Gouy, Emilie A. Delaune, Claire Monge, Jean‐Yves Exposito, Bernard Verrier · 2018 · Biomaterials
  9. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
    Rebecca Grainger, Alfred H.J. Kim, Richard P. Conway, Jinoos Yazdany, Philip Cameron Robinson · 2022 · Nature Reviews Rheumatology
  10. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications
    Amiri, Ala, Bagherifar, Rafieh, Ansari Dezfouli, Ehsan, Kiaie, Seyed Hossein, Jafari, Reza, Ramezani, Reihaneh · 2022 · Journal of Translational Medicine
  11. Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
    K. Swetha, Niranjan Goud Kotla, Lakshmi Tunki, Arya Jayaraj, Suresh K. Bhargava, Haitao Hu, Srinivasa Reddy Bonam, Rajendra Kurapati · 2023 · Vaccines
  12. Clinical and immunological effects of mRNA vaccines in malignant diseases
    Annkristin Heine, Stefan Juranek, Peter Brossart · 2021 · Molecular Cancer
  13. Organelle-level precision with next-generation targeting technologies
    Anand Saminathan, Matthew A. Zajac, Palapuravan Anees, Yamuna Krishnan · 2021 · Nature Reviews Materials
  14. Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
    Xinfu Zhang, Weiyu Zhao, Giang N. Nguyen, Chengxiang Zhang, Chunxi Zeng, Jingyue Yan, Shi Du, Xucheng Hou, Wenqing Li, Justin Jiang et al. · 2020 · Science Advances
  15. Targeting mRNA processing as an anticancer strategy
    Joana M. P. Desterro, Pedro Bak‐Gordon, Maria Carmo‐Fonseca · 2019 · Nature Reviews Drug Discovery
  16. Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells
    Margaret M. Billingsley, Alex G. Hamilton, David Mai, Savan K. Patel, Kelsey L. Swingle, Neil C. Sheppard, Carl H. June, Michael J. Mitchell · 2021 · Nano Letters
  17. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
    Chris R. Triggle, Devendra Bansal, Hong Ding, Md. Mazharul Islam, Elmoubasher Farag, Hamad Abdel Hadi, Ali A. Sultan · 2021 · Frontiers in Immunology
  18. Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials
    Jill Whitley, Christopher Zwolinski, Christian Denis, Maureen Maughan, Leonie Hayles, David Clarke, Meghan Snare, Hong Liao, Sean Chiou, Tina Marmura et al. · 2021 · Translational research
  19. mRNA vaccines for cancer immunotherapy
    Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan · 2022 · Frontiers in Immunology
  20. Delivery strategies of cancer immunotherapy: recent advances and future perspectives
    Zhongwei Zhao, Liyun Zheng, Weiqian Chen, Wei Weng, Jingjing Song, Jiansong Ji · 2019 · Journal of Hematology & Oncology
  21. Delivery of STING agonists for adjuvanting subunit vaccines
    Simon Van Herck, Bing Feng, Li Tang · 2021 · Advanced Drug Delivery Reviews
  22. Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes
    Shuai Liu, Xu Wang, Xueliang Yu, Qiang Cheng, Lindsay T. Johnson, Sumanta Chatterjee, Di Zhang, Sang M. Lee, Yehui Sun, Ting‐Chih Lin et al. · 2021 · Journal of the American Chemical Society
  23. Delivery Strategies for mRNA Vaccines
    Sivakumar Ramachandran, Soumya Ranjan Satapathy, Tathagata Dutta · 2022 · Pharmaceutical Medicine
  24. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
    Siew C. Ng, Ye Peng, Lin Zhang, Chris Ka Pun Mok, Shilin Zhao, Amy Li, Jessica Y. L. Ching, Yingzhi Liu, Shuai Yan, Dream L S Chan et al. · 2022 · Gut
  25. Chemical Strategies to Boost Cancer Vaccines
    Wenhao Li, Yanmei Li · 2020 · Chemical Reviews
  26. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
    Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, Peter Andrew McCullough · 2022 · Food and Chemical Toxicology
  27. Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
    Alexandra Suberi, Molly K. Grun, Tianyang Mao, Benjamin Israelow, Melanie Reschke, Julian Grundler, Laiba Akhtar, Teresa Lee, Kwangsoo Shin, Alexandra S. Piotrowski-Daspit et al. · 2023 · Science Translational Medicine
  28. mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
    Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, Ming-Hsiang Hong, Joyce Pei‐Yi Yuan, Jui-Ling Tsai, Han‐Chung Wu · 2023 · Journal of Biomedical Science
  29. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection
    Azadeh Rahimi, Azin Mirzazadeh, Soheil Tavakolpour · 2020 · Genomics
  30. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
    Kremsner, Peter G, Ahuad Guerrero, Rodolfo Andrés, Arana-Arri, Eunate, Aroca Martinez, Gustavo Jose, Bonten, Marc, Chandler, Reynaldo, Corral, Gonzalo, De Block, Eddie Jan Louis, Ecker, Lucie, Gabor, Julian Justin et al. · 2022 · The Lancet Infectious Diseases
  31. Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system
    Wang, Chang, Xue, Yonger, Markovic, Tamara, Li, Haoyuan, Wang, Siyu, Zhong, Yichen, Du, Shi, Zhang, Yuebao, Hou, Xucheng, Yu, Yang et al. · 2025 · Nature Materials
  32. RNA Nanotechnology-Mediated Cancer Immunotherapy
    Yao‐Xin Lin, Yi Wang, Sara Blake, Mian Yu, Lin Mei, Hao Wang, Jinjun Shi · 2019 · Theranostics
  33. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
    Maria Trovato, Rossella Sartorius, Luciana D’Apice, Roberta Manco, Piergiuseppe De Berardinis · 2020 · Frontiers in Immunology
  34. Recent Advancement in mRNA Vaccine Development and Applications
    Nojoud AL Fayez, Majed Saeed Nassar, Abdullah Awad Alshehri, Meshal K. Alnefaie, Fahad A. Almughem, Bayan Y. Alshehri, Abdullah O. Alawad, Essam A. Tawfik · 2023 · Pharmaceutics
  35. Nanotechnology-based mRNA vaccines
    Shuying Chen, Xiangang Huang, Yonger Xue, Ester Álvarez‐Benedicto, Yesi Shi, Wei Chen, Seyoung Koo, Daniel J. Siegwart, Yizhou Dong, Wei Tao · 2023 · Nature Reviews Methods Primers
  36. Nanoscale platforms for messenger RNA delivery
    Li, Bin, Zhang, Xinfu, Dong, Yizhou · 2019 · WIREs Nanomedicine and Nanobiotechnology
  37. High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA
    Yuan Rui, David R. Wilson, Stephany Yi Tzeng, Hannah M. Yamagata, Deepti Sudhakar, Marranne Conge, Cynthia A. Berlinicke, Donald J. Zack, Anthony D. Tuesca, Jordan J. Green · 2022 · Science Advances
  38. Eliciting B cell immunity against infectious diseases using nanovaccines
    Singh, Ankur · 2021 · Nature Nanotechnology
  39. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm
    Wei Wang, Shuo Feng, Zhuyifan Ye, Hanlu Gao, Jinzhong Lin, Defang Ouyang · 2021 · Acta Pharmaceutica Sinica B
  40. Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
    Singh, Satarudra Prakash, Pritam, Manisha, Pandey, Brijesh, Yadav, Thakur Prasad · 2021 · Journal of Medical Virology
  41. Are COVID-19 vaccines safe in pregnancy?
    Victoria H. Male · 2021 · Nature reviews. Immunology
  42. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
    János Szebeni, Gert Storm, Julia Y. Ljubimova, Mariana Castells, Elizabeth Jane Phillips, Keren Turjeman, Yechezkel Barenholz, Daan J.A. Crommelin, Marina A. Dobrovolskaia · 2022 · Nature Nanotechnology
  43. mRNA cancer vaccines: Advances, trends and challenges
    Qing He, Hua Gao, Dejiang Tan, Heng Zhang, Junzhi Wang · 2022 · Acta Pharmaceutica Sinica B
  44. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
    Bowen Li, Allen Yujie Jiang, Idris O. Raji, Caroline G. Atyeo, Theresa M. Raimondo, Akiva G. R. Gordon, Luke H. Rhym, Tahoura S. Samad, Corina MacIsaac, Jacob J. Witten et al. · 2023 · Nature Biomedical Engineering
  45. Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
    Kevin B. Ita · 2020 · Archives of Medical Research
  46. Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity
    Yaping Mai, Jueshuo Guo, Yue Zhao, Shijie Ma, Yanhui Hou, Jianhong Yang · 2020 · Cellular Immunology
  47. One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
    Dapeng Zhang, Elena N. Atochina‐Vasserman, Devendra S. Maurya, Ning Huang, Qi Xiao, Nathan A. Ona, Matthew Liu, Hamna Shahnawaz, Houping Ni, Kyunghee Kim et al. · 2021 · Journal of the American Chemical Society
  48. A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
    Peng Zhang, Elisabeth Narayanan, Qingbo Liu, Yaroslav Tsybovsky, Kristin L. Boswell, Shilei Ding, Zonghui Hu, Dean A. Follmann, Yin Lin, Huiyi Miao et al. · 2021 · Nature Medicine
  49. Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
    Yicheng Mo, Jiabing Ma, Hongtao Zhang, Junjie Shen, Jun Chen, Juan Hong, Yanmin Xu, Cheng Qian · 2022 · Frontiers in Cellular and Infection Microbiology
  50. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
    Zoltán Kis, Cleo Kontoravdi, Robin J. Shattock, Nilay Shah · 2020 · Vaccines
  51. SARS-CoV-2: characteristics and current advances in research
    Yicheng Yang, Zhiqiang Xiao, Kaiyan Ye, Xiaoen He, Bo Sun, Zhiran Qin, Jianghai Yu, Jinxiu Yao, Qinghua Wu, Zhang Bao et al. · 2020 · Virology Journal
  52. Emerging Technologies for Use in the Study, Diagnosis, and Treatment of Patients with COVID-19
    Tsikala Vafea, Maria, Atalla, Eleftheria, Georgakas, Joanna, Shehadeh, Fadi, Mylona, Evangelia K., Kalligeros, Markos, Mylonakis, Eleftherios · 2020 · Cellular and Molecular Bioengineering
  53. Nanobiomaterial-based vaccination immunotherapy of cancer
    Fangmin Chen, Yingjie Wang, Jing Gao, Madiha Saeed, Tianliang Li, Weiqi Wang, Haijun Yu · 2021 · Biomaterials
  54. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
    Minnaert, An-Katrien, Vanluchene, Helena, Verbeke, Rein, Lentacker, Ine, De Smedt, Stefaan C., Raemdonck, Koen, Sanders, Niek N., Remaut, Katrien · 2021 · Advanced Drug Delivery Reviews
  55. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
    Fatima Rizvi, Elissa Everton, Anna R. Smith, Hua Liu, Elizabeth Osota, Mitchell B. Beattie, Ying K. Tam, Norbert Pardi, Drew Weissman, Valerie Gouon–Evans · 2021 · Nature Communications
  56. Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
    Xing Huang, Tianyu Tang, Gang Zhang, Tingbo Liang · 2021 · Molecular Cancer
  57. Nanomedicine‐Boosting Tumor Immunogenicity for Enhanced Immunotherapy
    Jing Huang, Bin Yang, Yuan Peng, Jinsheng Huang, Siu Hong Dexter Wong, Liming Bian, Kangshun Zhu, Xintao Shuai, Shisong Han · 2021 · Advanced Functional Materials
  58. mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy
    Fengqiao Li, Xue‐Qing Zhang, William Ho, Maoping Tang, Zhongyu Li, Lei Bu, Xiaoyang Xu · 2023 · Nature Communications
  59. COVID-19: Progress in diagnostics, therapy and vaccination
    Xue Liu, Chao Liu, Gang Liu, Wenxin Luo, Ningshao Xia · 2020 · Theranostics
  60. A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications
    Furong Qin, Fan Xia, Hongli Chen, Bomiao Cui, Yun Feng, Ping Zhang, Jiao Chen, Min Luo · 2021 · Frontiers in Cell and Developmental Biology
  61. Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic
    Samagra Jain, Abhijeet K. Venkataraman, Marissa E. Wechsler, Nicholas A. Peppas · 2021 · Advanced Drug Delivery Reviews
  62. The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
    Linghui Qian, Xuefen Lin, Xue Gao, Rizwan Ullah Khan, Jia‐Yu Liao, Shubo Du, Jingyan Ge, Su Zeng, Shao Qin Yao · 2023 · Chemical Reviews
  63. Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
    Alexander J. Stephens, N. Burgess-Brown, Shisong Jiang · 2021 · Frontiers in Immunology
  64. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
    Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, Jhih‐Liang Huang, Fu‐Fei Hsu, Shih-Han Ko, Feng-Yi Ke, Shih-Chieh Su, Kang-Hao Liang, Joyce Pei‐Yi Yuan et al. · 2022 · Journal of Biomedical Science
  65. Leveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
    Zeng, Chunxi, Hou, Xucheng, Yan, Jingyue, Zhang, Chengxiang, Li, Wenqing, Zhao, Weiyu, Du, Shi, Dong, Yizhou · 2020 · Advanced Materials
  66. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
    Tsvetelina Veselinova Velikova, Tsvetoslav Georgiev · 2021 · Rheumatology International
  67. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development
    Xing Huang, Gang Zhang, Tianyu Tang, Tingbo Liang · 2021 · Molecular Cancer
  68. Porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and vaccines
    Zhiwei Li, Zhiqian Ma, Yang Li, Sheng Gao, Shuqi Xiao · 2020 · Microbial Pathogenesis
  69. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
    Kimberly Risma, Kathryn M. Edwards, Donna S. Hummell, Frédéric F. Little, Allison Eaddy Norton, Amy Polen Stallings, Robert A. Wood, Joshua D. Milner · 2021 · Journal of Allergy and Clinical Immunology
  70. Dilution-induced gel-sol-gel-sol transitions by competitive supramolecular pathways in water
    Lu Su, Jesús Mosquera, Mathijs F. J. Mabesoone, Sandra M. C. Schoenmakers, Cyprien Muller, Marle E. J. Vleugels, Shikha Dhiman, Stefan Wijker, Anja R. A. Palmans, Egbert W. Meijer · 2022 · Science
  71. mRNA vaccine in cancer therapy: Current advance and future outlook
    Youhuai Li, Mina Wang, Xueqiang Peng, Yingying Yang, Qishuang Chen, Jiaxing Liu, Qing She, Jichao Tan, Chuyuan Lou, Zehuan Liao et al. · 2023 · Clinical and Translational Medicine
  72. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
    Subodh Kumar Samrat, Anil Mathew Tharappel, Zhong Li, Hongmin Li · 2020 · Virus Research
  73. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs
    Godwell Nhamo, David Chikodzi, Hlengiwe Precious Kunene, Nthivhiseni Mashula · 2020 · Global Public Health
  74. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
    Jamile Ramos da Silva, Karine Bitencourt Rodrigues, Guilherme Formoso Pelegrin, Natiely Silva Sales, Hiromi Muramatsu, Mariângela de Oliveira Silva, Bruna F.M.M. Porchia, Ana Carolina Ramos Moreno, Luana R. M. M. Aps, Aléxia Adrianne Venceslau-Carvalho et al. · 2023 · Science Translational Medicine
  75. Tailor made: the art of therapeutic mRNA design
    Mihir Metkar, Christopher S. Pepin, Melissa J. Moore · 2023 · Nature Reviews Drug Discovery
  76. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
    Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo · 2021 · Molecular Pharmaceutics
  77. The use of RNA-based treatments in the field of cancer immunotherapy
    Mohammad Chehelgerdi, Matin Chehelgerdi · 2023 · Molecular Cancer
  78. The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5’ cap modulates protein expression in living cells
    Sikorski, Pawel J, Warminski, Marcin, Kubacka, Dorota, Ratajczak, Tomasz, Nowis, Dominika, Kowalska, Joanna, Jemielity, Jacek · 2020 · Nucleic Acids Research
  79. Translational precision medicine: an industry perspective
    Dominik Hartl, Valéria De Luca, Anna Kostikova, Jason M. Laramie, Scott Kennedy, Enrico Ferrero, Richard W. Siegel, Martin Fink, Sohail Ahmed, John M. Millholland et al. · 2021 · Journal of Translational Medicine
  80. CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets
    Yuying Zhang, Jingyan Luo, Weikang Yang, Wen-Chu Ye · 2023 · Cell Death and Disease
  81. Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination
    Elana Ben‐Akiva, Johan E. Karlsson, Shayan Hemmati, Hongzhe Yu, Stephany Yi Tzeng, Drew M. Pardoll, Jordan J. Green · 2023 · Proceedings of the National Academy of Sciences
  82. mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent
    Andaleeb Sajid, Jaqueline Matias, Gunjan Arora, Cheyne Kurokawa, Kathleen DePonte, Xiao‐Tian Tang, Geoffrey E. Lynn, Ming-Jie Wu, Utpal Pal, Norma Olivares Strank et al. · 2021 · Science Translational Medicine
  83. Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP
    Yi Lin, Ernst Wagner, Ulrich Lächelt · 2022 · Biomaterials Science
  84. A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo
    Sang M. Lee, Qiang Cheng, Xueliang Yu, Shuai Liu, Lindsay T. Johnson, Daniel J. Siegwart · 2020 · Angewandte Chemie International Edition
  85. High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models
    Lulu Xue, Alex G. Hamilton, Gan Zhao, Zebin Xiao, Rakan D. El-Mayta, Xuexiang Han, Ningqiang Gong, Xinhong Xiong, Junchao Xu, Christian G. Figueroa‐Espada et al. · 2024 · Nature Communications
  86. In vivo chimeric antigen receptor (CAR)-T cell therapy
    Adrian Bot, Andrew M. Scharenberg, Kevin M. Friedman, Lin T. Guey, Robert Hofmeister, James I. Andorko, Michael Klichinsky, Frank Neumann, Jagesh V. Shah, Andrew J. Swayer et al. · 2025 · Nature Reviews Drug Discovery
  87. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
    Alvin J. Mukalel, Rachel Riley, Rui Zhang, Michael J. Mitchell · 2019 · Cancer Letters
  88. Risk, Trust, and Flawed Assumptions: Vaccine Hesitancy During the COVID-19 Pandemic
    Omid V. Ebrahimi, Miriam Sinkerud Johnson, Sara Ebling, Ole Myklebust Amundsen, Øyvind Halsøy, Asle Hoffart, Nora Skjerdingstad, Sverre Urnes Johnson · 2021 · Frontiers in Public Health
  89. Efforts at COVID-19 Vaccine Development: Challenges and Successes
    Azizul Haque, Anudeep B. Pant · 2020 · Vaccines
  90. Nanomedicine-Based Approaches for mRNA Delivery
    Uchida, Satoshi, Perche, Federico, Pichon, Chantal, Cabral, Horacio · 2020 · Molecular Pharmaceutics
  91. Nanotechnology approaches in the current therapy of skin cancer
    Lívia Neves Borgheti-Cardoso, Juliana Santos Rosa Viegas, Ana Vitória Pupo Silvestrini, Angelo Luis Caron, Fabíola Silva Garcia Praça, Marcelo Kravicz, Maria Vitória Lopes Badra Bentley · 2020 · Advanced Drug Delivery Reviews
  92. Cationic Polymers as Transfection Reagents for Nucleic Acid Delivery
    Xiaomeng Cai, Rui Dou, Chen Guo, Jiaruo Tang, Xiajuan Li, Jun Chen, Jiayu Zhang · 2023 · Pharmaceutics
  93. Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
    Jisun Lee, Matthew Charles Woodruff, Eui Ho Kim, Jae‐Hwan Nam · 2023 · Experimental & Molecular Medicine
  94. Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
    Sarah J. Shepherd, Xuexiang Han, Alvin J. Mukalel, Rakan D. El-Mayta, Ajay S. Thatte, Jingyu Wu, Marshall Scott Padilla, Mohamad‐Gabriel Alameh, Neha Srikumar, Daeyeon Lee et al. · 2023 · Proceedings of the National Academy of Sciences
  95. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
    Ruklanthi de Alwis, Shiwei Chen, Esther Shuyi Gan, Eng Eong Ooi · 2020 · EBioMedicine
  96. Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines
    Anna K. Blakney, Paul F. McKay, Kai Hu, Karnyart Samnuan, Nikita Jain, Andrew Brown, Anitha M. Thomas, Paul Rogers, Krunal Polra, Hadijatou Sallah et al. · 2021 · Journal of Controlled Release
  97. Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
    Rossella Sartorius, Maria Trovato, Roberta Manco, Luciana D’Apice, Piergiuseppe De Berardinis · 2021 · npj Vaccines
  98. Codon optimality-mediated mRNA degradation: Linking translational elongation to mRNA stability
    Haneui Bae, Jeff M. Coller · 2022 · Molecular Cell
  99. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
    Savan K. Patel, Margaret M. Billingsley, C. Pritchett Frazee, Xuexiang Han, Kelsey L. Swingle, Jingya Qin, Mohamad‐Gabriel Alameh, Karin Wang, Drew Weissman, Michael J. Mitchell · 2022 · Journal of Controlled Release
  100. Nanomedicine and the COVID-19 vaccines
    2020 · Nature Nanotechnology